Mutated clotting gene raises risk of heart disease in blacks, not whites

April 23, 2001

Dallas, April 23 - A gene involved in blood clotting is linked to a six-fold increase in risk for heart disease in African-Americans, according to the first prospective study to examine the gene as it relates to heart disease published in the March 13th issue of Circulation: Journal of the American Heart Association.

"Our findings underscore the importance of studying genetic risk factors by ethnic group," says Kenneth K. Wu, M.D., Ph.D., lead author of the study and professor and director of the Hematology and Vascular Biology Research Center at the University of Texas, Houston Health Science Center. "They also provide a genetic basis for differential risk factors of heart attacks between African-Americans and whites." The gene in the study is the blueprint for a protein called thrombomodulin, which is found in the lining of the blood vessel walls. The protein converts the enzyme thrombin from a clotting agent into an anti-clotting agent. A common variance in the thrombomodulin gene occurs when alanine (an amino acid) is replaced by valine at amino acid position 455. This shift in gene structure has been previously associated with heart attack risk.

Genes give instructions on how amino acids link together to form proteins. Any shift in the order in which amino acids are linked can cause the protein to function abnormally. Reduced levels of normal thrombomodulin as a result of the altered gene may cause an increased tendency for blood vessel damage and blood clots.

"We have identified a genetic marker for predicting increased heart attack risk in African-Americans. Our results show that a single amino acid change in the thrombomodulin gene is an independent risk factor for coronary heart disease in blacks," says Wu.

The same small shift in the structure of the thrombomodulin gene was not associated with coronary heart disease (CHD) risk in white individuals.

Researchers recently analyzed the association of this structure with CHD in a prospective follow-up of the Atherosclerosis Risk in Communities (ARIC) study. ARIC is a population-based study that recruited 15,792 men and women ages 45-64 from four different communities in the United States. Baseline examinations, including blood pressures and samples of blood and DNA, were conducted between 1987 and 1989. Participants were reexamined on a three-year cycle.

Researchers identified 467 individuals who developed CHD during an average of five years of follow-up. Thrombomodulin genotypes at the 455 position were determined in 376 of these cases (23 percent black, 77 percent white), as well as a reference sample of 461 study participants. There are two copies of the thrombomodulin gene (one from each parent). Therefore genotypes are given as a two-letter "code." For example, a person with two copies of the unaltered form of the gene will have an AA genotype (alanine-alanine). Those with one regular form of the gene and one altered form will have an AV genotype (alanine-valine), those with two altered forms of the gene will be VV (valine-valine). Researchers combined the VV and AV results in their analysis.

African-Americans with at least one copy of the altered form of thrombomodulin (AV or VV) had a 6.1 times greater risk for CHD after adjustment for other CHD risk factors. In contrast, the AV or VV genotype was not significantly associated with CHD risk in whites.

The AA genotype was more common in those without CHD. Ninety-eight out of 105 (93 percent) of healthy blacks and 237 out of 356 (67 percent) of healthy whites had the AA genotype.

Why the thrombomodulin-455 structure is associated with higher risk of CHD in blacks than whites is not clear. Wu says one possible explanation is that the gene may act differently in blacks than whites. "It is likely that the valine structure is a risk factor for heart attacks in all blacks in the United States, since ARIC is a population-based study. However, I would like to caution that the number of African-Americans with CHD in our study group is relatively small when compared to the number of white cases," says Wu. The group is analyzing a large number of cases to substantiate the results of this study.
The research team plans to study the association of heart attacks and stroke with other genes that affect clotting.

Co-authors include Nena Aleksic, Ph.D.; Chul Ahn, Ph.D.; Eric Boerwinkle, Ph.D.; Aaron R. Folsom, M.D.; and Harinder Juneja, M.D.

This study was supported by the National Heart, Lung and Blood Institute, NIH.

For journal copies only,
please call: 214-706-1396
For other information, call:
Carole Bullock: 214-706-1279
Maggie Francis: 214-706-1397

NR01--1284 (Circ/Wu)

American Heart Association

Related Heart Disease Articles from Brightsurf:

Cellular pathway of genetic heart disease similar to neurodegenerative disease
Research on a genetic heart disease has uncovered a new and unexpected mechanism for heart failure.

Mechanism linking gum disease to heart disease, other inflammatory conditions discovered
The link between periodontal (gum) disease and other inflammatory conditions such as heart disease and diabetes has long been established, but the mechanism behind that association has, until now, remained a mystery.

New 'atlas' of human heart cells first step toward precision treatments for heart disease
Scientists have for the first time documented all of the different cell types and genes expressed in the healthy human heart, in research published in the journal Nature.

With a heavy heart: How men and women develop heart disease differently
A new study by researchers from McGill University has uncovered that minerals causing aortic heart valve blockage in men and women are different, a discovery that could change how heart disease is diagnosed and treated.

Heart-healthy diets are naturally low in dietary cholesterol and can help to reduce the risk of heart disease and stroke
Eating a heart-healthy dietary pattern rich in vegetables, fruits, whole grains, low-fat dairy products, poultry, fish, legumes, vegetable oils and nuts, which is also limits salt, red and processed meats, refined-carbohydrates and added sugars, is relatively low in dietary cholesterol and supports healthy levels of artery-clogging LDL cholesterol.

Pacemakers can improve heart function in patients with chemotherapy-induced heart disease
Research has shown that treating chemotherapy-induced cardiomyopathy with commercially available cardiac resynchronization therapy (CRT) delivered through a surgically implanted defibrillator or pacemaker can significantly improve patient outcomes.

Arsenic in drinking water may change heart structure raising risk of heart disease
Drinking water that is contaminated with arsenic may lead to thickening of the heart's main pumping chamber in young adults, according to a new study by researchers at Columbia University Mailman School of Public Health.

New health calculator can help predict heart disease risk, estimate heart age
A new online health calculator can help people determine their risk of heart disease, as well as their heart age, accounting for sociodemographic factors such as ethnicity, sense of belonging and education, as well as health status and lifestyle behaviors.

Wide variation in rate of death between VA hospitals for patients with heart disease, heart failure
Death rates for veterans with ischemic heart disease and chronic heart failure varied widely across the Veterans Affairs (VA) health care system from 2010 to 2014, which could suggest differences in the quality of cardiovascular health care provided by VA medical centers.

Heart failure: The Alzheimer's disease of the heart?
Similar to how protein clumps build up in the brain in people with some neurodegenerative diseases such as Alzheimer's and Parkinson's diseases, protein clumps appear to accumulate in the diseased hearts of mice and people with heart failure, according to a team led by Johns Hopkins University researchers.

Read More: Heart Disease News and Heart Disease Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to